SCHEMBL5461007

SCHEMBL5461007

Cc1cccnc1NC(=O)N1CC=C(c2ccc(NC(=O)Nc3ccccc3F)cc2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.51
NPC1 O15118 5/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
ALDH1A1 P00352 2/20 0.51
ALOX15 P16050 2/20 0.51
MAPT P10636 1/20 0.51
HPGD P15428 1/20 0.51
CASP3 P42574 1/20 0.51
SENP8 Q96LD8 1/20 0.51
SENP7 Q9BQF6 1/20 0.51
SENP6 Q9GZR1 1/20 0.51
KDM4E B2RXH2 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
NAMPT P43490 11/20 0.48
TSHR P16473 1/20 0.47
TRPV1 Q8NER1 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5473690 0.88 GFER (0.60) RAB9ANPC1SMN1; SMN2ALDH1A1ALOX15
SCHEMBL5456914 0.87 ALDH1A1 (0.48) RAB9ANPC1SMN1; SMN2ALDH1A1ALOX15
SCHEMBL5465544 0.84 NPC1 (0.55) RAB9ANPC1SMN1; SMN2ALDH1A1ALOX15
SCHEMBL5462735 0.83 GFER (0.48) RAB9ANPC1SMN1; SMN2ALDH1A1ALOX15
SCHEMBL5452210 0.82 RAB9A (0.55) RAB9ANPC1SMN1; SMN2ALDH1A1ALOX15
SCHEMBL5460127 0.82 MAPT (0.47) RAB9ANPC1SMN1; SMN2ALDH1A1ALOX15
SCHEMBL5470995 0.80 RAB9A (0.51) RAB9ANPC1SMN1; SMN2ALDH1A1MAPT
SCHEMBL5463378 0.80 NPC1 (0.58) RAB9ANPC1SMN1; SMN2ALDH1A1ALOX15
SCHEMBL5458381 0.77 NAMPT (0.48) RAB9ANPC1SMN1; SMN2ALDH1A1ALOX15
SCHEMBL5473571 0.77 TRPV1 (0.49) RAB9ANPC1SMN1; SMN2MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070249620-A1 Urea Derivative SANKYO COMPANY, LIMITED (JP) 2007-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249620-A1 Urea Derivative UGP2, SLC14A1, DGAT1 RAB9A 1528/4885NPC1 1089/4885SMN1; SMN2 4424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.